FdaApplication
NDA 202543
Identifiers
- fda_app_no: NDA202543
Properties
| Property | Value |
|---|---|
| applicant_name | HQ SPECIALTY PHARMA CORP |
| application_type | NDA |
| approval_date | 2011-11-09 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | 1.5GM/100ML (15MG/ML) | INJECTABLE;INTRAVENOUS |
| LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | 250MG/50ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INTRAVENOUS |
| LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | 500MG/100ML (5MG/ML) | INJECTABLE;INTRAVENOUS |
| LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | 1GM/100ML (10MG/ML) | INJECTABLE;INTRAVENOUS |
4 products